KDM1A and cancer: A host of classical amine oxidase inhibitors, such as tranylcypromine (TCP), pargyline, and phenelzine, together with LSD1 tool compounds, such as SP-2509 and GSK-LSD1, have been extensively utilized in LSD1 mechanistic cancer studies.